Top Markets
Coin of the day
Paion AG Paion AG

Paion AG

PA8
Classifica tra le azioni #35969
Paion AG is a specialized pharmaceutical firm engaged in the global development... Paion AG is a specialized pharmaceutical firm engaged in the global development and commercialization of medicines for hospital settings, specifically addressing needs in sedation, anesthesia, and critical care. Its primary compound, Remimazolam, is an ultra-short-acting intravenous benzodiazepine designed as a sedative/anesthetic, currently progressing through clinical trials for applications in procedural sedation, general anesthesia, and intensive care unit sedation. The company's pipeline also includes Angiotensin II, a vasoconstrictor for treating severe low blood pressure in adults experiencing septic or other forms of distributive shock, and Eravacycline, a new fluorocycline antibiotic targeting complex intra-abdominal infections in adults. Paion AG collaborates with various partners through licensing and strategic agreements, including Cosmo Pharmaceuticals, Wuhan Humanwell Innovative Drug Research and Development Center Limited Company, Hana Pharm, Yichang Humanwell, and Mundipharma. Established in 2000, Paion AG operates from Aachen, Germany.
Prezzo delle azioni
$0.42701586
Ultima sincronizzazione: 2023-11-01
Capitalizzazione di mercato
$3.21M
Variazione (1 giorno)
16.99%
Variazione (1 anno)
0.00%
Paese
DE
Scambia Paion AG (PA8)

Categoria

Storico del prezzo dell'azione per Paion AG (PA8)
Prezzo di chiusura più alto: $0.43 il 2023-11-01

Prezzo di chiusura più basso: $9.35 il 2022-11-01
Storico del prezzo dell'azione di Paion AG dal 2022 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2023 -93.62%
2022 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$171.67 -
DE
$161.67 23.26%
DE
$36.61 22.16%
JP
$225.00 37.51%
CH
$21.30 13.79%
IN